MYCELIUM SOFTWARE INC. – Trademark Portfolio
Entity Type: 03
MYCELIUM SOFTWARE INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include ROCKETIUM. The owner is based in REDMOND, WA.
1751, NORTH EAST 90TH STREET, C219
REDMOND, WA 98052
Showing of trademarks Trademarks
Trademark Classifications
MYCELIUM SOFTWARE INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does MYCELIUM SOFTWARE INC. have?
MYCELIUM SOFTWARE INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does MYCELIUM SOFTWARE INC. file in?
MYCELIUM SOFTWARE INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are MYCELIUM SOFTWARE INC.'s most well-known trademarks?
MYCELIUM SOFTWARE INC.'s registered trademark portfolio includes well-known marks such as ROCKETIUM. These are among 1 currently registered trademark in the portfolio.
What is MYCELIUM SOFTWARE INC.'s trademark registration success rate?
MYCELIUM SOFTWARE INC. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.